l-carnitine vs meldonium reduces production through competitive inhibition Fluorinated Carnitine Derivatives as Tools
Description
P.MillerM.BodenW

[DOI] [PubMed] [Google Scholar] 85.Gordon A.N., Moore S.R., Patterson N.D., Hostetter M.E., Cabre H.E., Hirsch K.R., Hackney A.C., Smith-Ryan A.E

J.KoethR.LevisonB

The compound occurs naturally in the human body - the intra-corporeal production of L-carnitine takes place in the liver and kidneys, and the substance is accumulated primarily in the heart muscle and skeletal muscles

Published online February 16, 2015 DOI: 11,398 View 73 Download 77 Web of Science 78 Crossref Abstract PDFPubReader ePub Non-alcoholic fatty liver disease, which is considered a hepatic manifestation of metabolic syndrome, independently increases the risks of developing cardiovascular disease (CVD) and type 2 diabetes mellitus
